Ideal Cures Launches Two New Film Coating Products INSTACOAT QD and INSTACOAT T2F at the 2nd FDD Conclave

Food and Healthcare Press Releases Thursday July 5, 2018 14:29
MUMBAI, India--5 Jul--PRNewswire/InfoQuest

Ideal Cures, an Indian company headquartered in Mumbai, India, launched two new ready-to-use film coating products INSTACOAT QD and INSTACOAT T2F, at the 2nd Formulation and Drug Delivery Conclave (FDD), held on 15th-16th June 2018, at Hyderabad, India where more than 110 formulators of top India based pharma companies were present.

(Logo: https://mma.prnewswire.com/media/714539/Ideal_Cures_Logo.jpg )
INSTACOAT QD, quick disintegrating film coating product is revolutionary for pharmaceutical applications which provides fast disintegration of film within 3-30 seconds.

INSTACOAT T2F is a brilliant ready-to-use coating product by Ideal Cures that is completely free from Talc and TiO2. This product was developed because there have been many speculations, questions and concerns about talc and titanium dioxide as being carcinogenic. Hence, their use is discouraged in Europe and US.

Mr. Suresh Pareek, Managing Director of Ideal Cures Pvt. Ltd., who is also one of the inventors, said, "Ideal Cures is driven by its vision to provide the best solutions to the industry by continuously developing new and innovative products. We aimed to add another milestone to our mission of assisting the pharma industry with its need for better drug delivery systems and regulatory compliances with these two products."

About Ideal Cures:

Ideal Cures (IC) is amongst India's leading manufacturer and exporter of pharmaceutical excipients and ready-to-use coating systems for solid oral dosage forms. IC provides tailor-made solutions and products for the pharmaceutical and allied industries, through a network of customers and partners across more than 40 countries around the world. It is the first film coating company to have all its cGMP compliant manufacturing plants EXCiPACT(TM) certified. IC's latest manufacturing facility in Sikkim will be certified in due course. An ISO 9001:2015 certified company with a US DMF for all its manufacturing facilities; IC is one of the most innovative film-coating companies.

For a comprehensive, time-saving tablet coating experience, Talk to Us!
Join us on   LinkedIn for quick updates on our new product launches and upcoming events!
Media Contact:
Saryu Pareek Gupta
Vice President - Corporate Communications
Ideal Cures Pvt. Ltd., Mumbai, India
+91-2242688700
Email: pareeksaryu@idealcures.co.in
Web - http://www.idealcures.com
India HO and R&D centre
A-223 to 229, Virwani Industrial estate
Off western express highway
Goregaon (East), Mumbai - 4000063
India
Source: Ideal Cures Private Limited

Latest Press Release

Grunenthal Acquires Averitas Pharma and Establishes Commercial Footprint in the US

Grunenthal announced today that it has acquired the US-based pharmaceutical company Averitas Pharma, thereby extending its commercial footprint to the United States. Averitas Pharma will be commercialising the pain patch Qutenza(R) (8 % capsaicin) for...

Ascensia Diabetes Care Highlights the Support That Families Provide for People With Diabetes To Mark World Diabetes Day 2018

Today, Ascensia Diabetes Care, a global leading diabetes care company, launched their campaign for World Diabetes Day 2018 to celebrate the important role of families for people with diabetes. They are publishing 38 online artworks that tell the stories...

Qatar Foundation Ushers in New Era of Healthcare With Official Inauguration of Sidra Medicine

Her Highness Sheikha Moza bint Nasser, Chairperson of Qatar Foundation (QF), today officially inaugurated Sidra Medicine - a brand new, world-leading women's and children's hospital in Qatar. The grand opening reflects the country's broader focus and...

Singapore National Eye Centre, Singapore Eye Research Institute And Johnson Johnson Vision Set Sights On Halting Global Myopia Epidemic

New US$26.35 Million Collaboration Seeks Prevention and Treatment Solutions to Address Rising Burden of Condition The Singapore National Eye Centre (SNEC), the Singapore Eye Research Institute (SERI) and Johnson & Johnson Vision today announced a...

TIENS Group Launches Global Expansion Into New Retail

Leading healthcare company, TIENS Group, has announced their global expansion into the new retail market with the opening of a new flagship TIENS Experience Store in China. Located in the TIENS International Health Industrial Park, the new store features...

Related Topics